Zions Bancorporation enters its July 20 earnings report with an unusual setup: short sellers are actively reducing exposure even as the stock edges higher, and a broad wave of analyst target raises signals the Street is revising its view of the bank's prospects upward.
The most striking move in positioning is the sharp retreat in short interest. Shorts fell nearly 13% on the week to 4.1% of free float — roughly 6.1 million shares — unwinding a build that had pushed the position above 7.7 million shares in late June. The direction of travel is clear: that June peak was the highest level of the past six weeks, and sellers have been covering consistently since. Borrow conditions give them little reason to stay put. Cost to borrow remains negligible at under 0.49%, and availability is essentially unlimited — more than 109 million shares remain lendable against roughly 6 million borrowed, making this one of the loosest borrow markets in the regional bank universe. That kind of setup offers no squeeze pressure and no urgency for shorts to hold their ground.
Options tell a modestly more cautious story, though not an alarming one. The put/call ratio has climbed to 0.74, running above its 20-day average of 0.65 by about 1.3 standard deviations. The ratio drifted higher across the past two weeks — from around 0.58 in late June to where it is now — which points to a measured uptick in demand for downside protection ahead of Sunday evening's results. That said, the reading is nowhere near stressed territory; the 52-week high is 1.68, and the current level reflects mild hedging rather than outright fear.
The analyst community is the clearest bullish signal of the week. Every target raise in the past three weeks has been upward, and the moves are material. Cantor Fitzgerald lifted its target to $80 from $69 on July 15, reiterating Overweight. JP Morgan moved to $75 from $67 on July 1, and Morgan Stanley went to $77 from $68 on June 29. Even firms with neutral-to-hold ratings joined the revision cycle: Truist raised its Hold target to $72 from $66, and Wells Fargo's Mike Mayo moved his Equal-Weight target to $66 from $63. The consensus mean now sits at $72.67 — a narrow premium to the current $70.42 close — but the direction of travel in targets has been uniformly higher across bulls and bears alike. The bull case centres on Zions' commercial banking focus, fee income diversification, and improving operating leverage; the bear case is primarily a margin and expense story, with net interest income growth seen as a limiting factor on profitability.
Valuation has re-rated alongside the targets. The price-to-earnings multiple has expanded by roughly 1.4 points over the past 30 days to about 10.7x, and price-to-book has moved to 1.27x — both modest for a regional bank but no longer as compressed as they were in early June. EPS momentum is a genuine positive: factor scores place the stock in the 80th percentile on 30-day EPS momentum and 77th on the 90-day window, suggesting estimates have been moving in the right direction ahead of the print. The ORTEX short score has drifted lower over the past week, from above 40 to 37.9 — reflecting the short covering rather than any deterioration in the bull case.
The last two quarterly reports produced modest negative reactions, with ZION slipping around 1–2% the following day each time. With the stock up 4.7% on the month and shorts reducing exposure into the print, the focus on July 20 is less about whether the shorts are right and more about whether NIM guidance and deposit trends confirm the Street's increasingly constructive view.
See the live data behind this article on ORTEX.
Open ZION on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
